Top Markets
Coin of the day
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Pozycja w akcjach #30384
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Cena akcji
$1.25
Ostatnia synchronizacja: 2026-08-18
Kapitalizacja rynkowa
$17.05M
Zmiana (1 dzień)
-1.50%
Zmiana (1 rok)
-22.24%
Kraj
FR
Handel Aelis Farma S.A. (AELIS)

Kategoria

Historia stopy dywidendy dla Aelis Farma S.A. (AELIS)
Stopa dywidendy (TTM) dla Aelis Farma S.A. (symbol akcji: AELIS) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Aelis Farma S.A. (AELIS) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE